Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation

Cancer Research

Volumn 62, Issue 4, 2002, Pages 1069-1076

  Shono, Tadahisa ^a   Tofilon, Philip J ^a   Schaefer, Timothy S ^a   Parikh, Dipen ^a   Lang, Frederick F ^a   Liu, Ta Jen ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CARMUSTINE; CISPLATIN; LIPOCORTIN 5; PROTEIN P53; SERINE;

APOPTOSIS; ARTICLE; CHEMOSENSITIVITY; CONTROLLED STUDY; DNA DAMAGE; GENE TRANSFER; GLIOMA; HUMAN; HUMAN CELL; IONIZING RADIATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RADIOSENSITIZATION; VIRAL GENE THERAPY; WESTERN BLOTTING;

ADENOVIRIDAE; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARMUSTINE; CISPLATIN; DNA DAMAGE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, P53; GENETIC VECTORS; GLIOMA; HUMANS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036173666     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Epidemiology of brain tumors: The national survey of intracranial neoplasms
2. Mutations in the p53 gene occur in diverse human turnout types
3. p53 mutations in human malignant gliomas: Comparison of loss of heterozygosity with mutation frequency
4. A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme
5. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas
6. Pathways leading to glioblastoma multiforme: A molecular analysis of genetic alterations in 65 astrocytic tumors
7. Loss of wild-type p53 bestows a growth advantage on primary cortical astrocytes and facilitates their in vitro transformation
8. The p53 gene and its role in human brain tumors
9. p53, the cellular gatekeeper for growth and division
10. p53: Death star
11. Gene therapy for cancer: What have we done and where are we going?
12. Adenovirus-mediated p 53 gene therapy for human gliomas
13. Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis
14. Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo
15. Adenovirus-mediated p53 gene delivery inhibits 9L glioma growth in rats
16. Preliminary results of a Phase I clinical trial of adenovirus-mediated p53 gene therapy for recurrent glioma: Biological studies
17. Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis
18. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene
19. Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation
20. Adenovirus-mediated wild-type p53 gene expression radiosensitizes non-small cell lung cancer cells but not normal lung fibroblasts
21. Regulation of p53 in response to DNA damage
22. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
23. DNA damage induces phosphorylation of the amino terminus of p53
24. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage
25. Mutations in serines 15 and 20 of human p53 impair its apoptotic activity
26. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2
27. p53AIPI, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53
28. New developments in the multi-site phosphorylation and integration of stress signalling at p53
29. Phosphorylation of p53 serine 15 increases interaction with CBP
30. Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy
31. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing
32. Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells
33. Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53
34. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life
35. The p53 pathway
36. Regulation of p53 function and stability by phosphorylation
37. Enhanced phosphorylation of p53 by ATM in response to DNA damage
38. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53
39. Cisplatinum and Taxol induce different patterns of p53 phosphorylation
40. Functional activation of p53 via phosphorylation following DNA damage by UV but not γ radiation
41. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells
42. Phenotypic alterations of small cell lung carcinoma induced by different levels of wild-type p53 expression
43. p53 function and dysfunction
44. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53
45. DNA damage-induced activation of p53 by the checkpoint kinase Chk2
46. Wild-type p53 inhibits protein kinase CK2 activity
47. Cancer. P53, guardian of the genome
48. Differential p53, p21, mdm2 and Rb regulation in glioma cell lines that expends wild-type p53